12.950
−6,83%
2026-10-15
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +6.1% | -30.5% | 1 / 3 | -58.8% | +15.26 pp | +38.60 pp | +14.3% | 0.00 | 6.94 | 16,5 | −58,8% | 10,4 | +6,1% | 6.94 | 7.16 | −3,0% |
| Pts | 0 | 0 | 4 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 12.950 (close price on 2026-10-15)EPS (TTM): 1.865
Financial charts
1.Revenue & growth
VND bn16,5Q2/26
1.Revenue & growth
VND bn16,5Q2/26
2.Profit & growth
VND bn10,4Q2/26
3.Profit mix (Penman)
VND bn16,5Q2/26
4.Margins & cost structure
%18.3%Q2/26
5.Returns & cash cycle
% · days7.5%Q2/26
6.Earnings quality & cash
VND bn43,5Q2/26
7.Asset structure
VND bn121Q2/26
8.Funding & debt health
VND bn · times121Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %6,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.303Q2/26
Adjusted EPS growth, latest quarter
6.1%
Average adjusted EPS growth, 3 quarters
-30.5%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26